Research on triple-negative breast cancer has led to findings about the role of MGAT1-guided complex N-glycans on CD73 in immune evasion. This discovery may have implications for cancer immunotherapy, potentially leading to new ways to enhance the effectiveness of T-cells in fighting cancer. The study's connection to broader topics in pharmacology, chemical biology, and cancer treatment is also being noted in various scientific and medical communities.